ID: ALA3093942

Max Phase: Preclinical

Molecular Formula: C20H22F3N3O5S

Molecular Weight: 473.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#CCNC(=O)[C@@H]1C[C@@H](S(=O)(=O)c2ccccc2C(F)(F)F)C[C@H]1C(=O)N1CCOCC1

Standard InChI:  InChI=1S/C20H22F3N3O5S/c21-20(22,23)16-3-1-2-4-17(16)32(29,30)13-11-14(18(27)25-6-5-24)15(12-13)19(28)26-7-9-31-10-8-26/h1-4,13-15H,6-12H2,(H,25,27)/t13-,14-,15-/m1/s1

Standard InChI Key:  UUEOZYQFUVCPBN-RBSFLKMASA-N

Associated Targets(Human)

Cathepsin K 3011 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cathepsin S 3285 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

A20 109 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 473.47Molecular Weight (Monoisotopic): 473.1232AlogP: 1.37#Rotatable Bonds: 5
Polar Surface Area: 116.57Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.28CX Basic pKa: CX LogP: 0.17CX LogD: 0.17
Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.65Np Likeness Score: -1.51

References

1. Hilpert H, Mauser H, Humm R, Anselm L, Kuehne H, Hartmann G, Gruener S, Banner DW, Benz J, Gsell B, Kuglstatter A, Stihle M, Thoma R, Sanchez RA, Iding H, Wirz B, Haap W..  (2013)  Identification of potent and selective cathepsin S inhibitors containing different central cyclic scaffolds.,  56  (23): [PMID:24224654] [10.1021/jm401528k]

Source